VISIT US IN CHICAGO JUNE 2-4 AT BOOTH 2073!

Search Videos by Topic or Participant
Browse by Series:

Case Study: Importance of Iron Chelation Therapy in MDS

Panelists: Azra Raza, MD
Published: Thursday, Apr 02, 2015
For High-Definition, Click
Azra Raza, MD, has been dedicated to treating and researching myelodysplastic syndrome (MDS) for over 30 years. In an average week, Raza treats approximately 50 patients with MDS, which has led to an in-depth understanding of the chronic morbidities associated with this disease, including iron overload.

As an example of the importance of iron chelation therapy (ICT), Raza describes a male patient with low-risk MDS in his late 60s who developed signs of chronic iron overload following treatment. However, the patient was resistant to receiving ICT, which resulted in his hospitalization for acute heart failure.

A T2* MRI showed immense iron overload with a ferritin level greater than 7000 µg/g, which required aggressive ICT. After nearly 2 months of treatment, the patient was released from the hospital. This case study demonstrates the dangers associated with not managing iron levels, Raza suggests.
Slider Left
Slider Right
For High-Definition, Click
Azra Raza, MD, has been dedicated to treating and researching myelodysplastic syndrome (MDS) for over 30 years. In an average week, Raza treats approximately 50 patients with MDS, which has led to an in-depth understanding of the chronic morbidities associated with this disease, including iron overload.

As an example of the importance of iron chelation therapy (ICT), Raza describes a male patient with low-risk MDS in his late 60s who developed signs of chronic iron overload following treatment. However, the patient was resistant to receiving ICT, which resulted in his hospitalization for acute heart failure.

A T2* MRI showed immense iron overload with a ferritin level greater than 7000 µg/g, which required aggressive ICT. After nearly 2 months of treatment, the patient was released from the hospital. This case study demonstrates the dangers associated with not managing iron levels, Raza suggests.
View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
34th Annual Miami Breast Cancer Conference® Clinical Case Vignette Series™May 25, 20182.0
Community Practice Connections™: CDK4/6 Inhibitors With the Experts: The Role of Emerging Agents for the Management of Metastatic Breast CancerMay 30, 20182.0
Publication Bottom Border
Border Publication
x